XOMA Royalty Corp
corporate_fare Company Profile
XOMA Royalty Corp (NASDAQ:XOMA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 19 items for XOMA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-12, rated 8/10. Across its 19 most recent items scored 7 or higher, the top rating is 10/10, with 13 rated 8 or above. Recent SEC coverage for XOMA spans DEFA14A, 8-K, DEFM14A, 425.
Recent high-impact activity:
- XOMA Royalty Confirms Merger Closing Date, Redeems $68.6M Preferred Stock, and Sets CVR Record Date
- XOMA Royalty Sets July 14 Target for Ligand Acquisition Close, Redeems All Preferred Stock
- XOMA Royalty Sets Merger Closing Date, Redeems Preferred Stock, and Announces CVR Record Date
- Shareholder Vote Scheduled for Ligand Pharmaceuticals Acquisition at $39.00 Cash Plus Contingent Value Right
- XOMA Royalty Files Definitive Proxy for Ligand Merger, Details $39 Cash Plus Contingent Value Right
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$52.15M
Net Income
$31.71M
Diluted EPS
$1.46
Op. Cash Flow
$2.87M
Operating Income
$11.38M
Cash & Equivalents
$82.91M
Total Debt
$108.98M
Debt / Equity
1.30×
Net Margin
60.8%
Shares Outstanding
11.86M sh
Source: 10-K · filed 2026-03-18 · accession 0001104659-26-030872
feed XOMA - Latest Insights
XOMA
Jun 12, 2026, 5:24 PM EDT
XOMA
Jun 12, 2026, 5:23 PM EDT
XOMA
Jun 12, 2026, 5:22 PM EDT
XOMA
Jun 10, 2026, 5:19 PM EDT
XOMA
May 26, 2026, 11:28 AM EDT
XOMA
May 22, 2026, 6:01 AM EDT
XOMA
May 18, 2026, 5:29 PM EDT
XOMA
May 18, 2026, 5:26 PM EDT
XOMA
May 01, 2026, 9:16 PM EDT
XOMA
Apr 29, 2026, 5:43 PM EDT
XOMA
Apr 27, 2026, 8:19 AM EDT
XOMA
Apr 27, 2026, 8:16 AM EDT
XOMA
Apr 27, 2026, 6:12 AM EDT
XOMA
Mar 30, 2026, 5:32 PM EDT
XOMA
Mar 18, 2026, 6:45 AM EDT
XOMA
Mar 02, 2026, 6:04 AM EST
XOMA
Feb 09, 2026, 4:19 PM EST
XOMA
Feb 02, 2026, 4:33 PM EST
XOMA
Jan 15, 2026, 4:25 PM EST